For instance, low-dose anti-VEGFR2 antibody homogenized functional tumor vessels, relieving hypoxia and reprogramming immunosuppressive M2-like TAM towards an M1-like, pro-inflammatory state. This evidence concerns the gene KDR and neoplasm.